CEVA, Inc. — Q1 2015 Form 10-Q
Reporting period: Three months ended March 31, 2015; unaudited results compared with Q1 2014. CEVA licenses DSP, vision, audio, cellular and connectivity intellectual property to semiconductor companies and equipment manufacturers.
Key financial results
| Metric | Q1 2015 | Q1 2014 |
|---|---|---|
| Revenue | $13.834 million | $13.674 million |
| Licensing and related revenue | $7.839 million | $7.906 million |
| Royalties | $5.995 million | $5.768 million |
| Gross profit / margin | $12.649 million / 91% | $12.562 million / 92% |
| Operating expenses | $12.086 million | $10.429 million |
| Operating income | $0.563 million | $2.133 million |
| Net income | $0.486 million | $1.985 million |
| Diluted earnings per share | $0.02 | $0.09 |
| Cash from operations | $(0.672) million | $4.799 million |
Operating margin fell to about 4% from 16%. The filing reports no borrowings; total liabilities were $28.4 million at March 31. Cash, short- and long-term bank deposits, and marketable securities totaled approximately $128.1 million, down from $129.9 million at year-end 2014. Cash and cash equivalents alone were $14.0 million. Total assets were $211.2 million and stockholders’ equity was $182.7 million.
Changes versus prior year
- Revenue increased 1%, driven by 4% higher royalties; licensing revenue declined 1%.
- Reported customer chipset shipments incorporating CEVA technology rose to 233 million from 212 million. Higher baseband and LTE royalties were partly offset by lower legacy non-baseband royalties and lower royalty rates on Bluetooth shipments.
- Operating expenses rose 16%, primarily reflecting RivieraWaves personnel and retention costs, project spending, commissions, and acquired-intangible amortization. R&D expense increased to $7.4 million from $6.0 million.
- Net income fell to $0.5 million from $2.0 million. In addition to higher operating costs, net financial results shifted to a $27,000 loss from $460,000 of income, including a $402,000 foreign-exchange loss.
- Operating cash flow moved from $4.8 million provided to $0.7 million used, principally reflecting higher receivables and prepaid expenses. Investing activities used $1.0 million; financing activities used $0.5 million.
Outlook, management commentary and risks
- Management cited a record 12 licensing agreements signed in Q1, including eight with first-time customers, and described the licensing pipeline as healthy. It expects quarterly licensing revenue in the range of $6 million to $7.5 million.
- Management expects non-cellular royalty-bearing shipments to grow from approximately 86 million units in 2014 to 700–900 million annually by 2018. It expects cellular baseband to remain a significant growth driver, while noting these statements are forward-looking and subject to risks.
- Management said available cash, deposits, marketable securities and operating cash flow should fund operations for at least 12 months, subject to revenue and expense assumptions. No specific earnings or revenue guidance for the full year was provided.
- The 2014 RivieraWaves acquisition added Wi-Fi and Bluetooth IP. CEVA paid $2.7 million of contingent consideration during Q1; $1.0 million remained expected to be paid in 2015. The filing estimates RivieraWaves-related quarterly operating expenses at about $1.7 million in 2015, plus roughly $0.4 million quarterly for acquired-intangible amortization and equity compensation.
- Key risks include customer and royalty concentration, competitive and pricing pressure, dependence on cellular baseband and handset markets, unpredictable licensing timing and customer shipments, acquisition integration and costs, foreign-exchange exposure, and reliance on research grants and tax benefits. Two customers represented 25% and 14% of Q1 revenue; the five largest represented 55%. The filing reports no material legal proceedings and no material change in internal controls.
Important facts for investors to verify
- Whether new licensing agreements convert to product deployments and recurring royalties, and whether customer concentration declines.
- Whether revenue growth can outpace acquisition-related and R&D costs, given the sharp year-over-year decline in operating income and net income.
- Whether operating cash flow recovers as receivables and prepaid expenses unwind.
- Progress integrating RivieraWaves, remaining contingent consideration and retention-plan costs, and the realization of anticipated benefits.
- Exposure to Euro and Israeli shekel movements, customer credit risk, and continued eligibility for research grants and tax benefits.